Xiangyang Xiong

967 citations
35 papers · 657 indexed · h-index 15
Topics
Chemokine receptors and signaling (5 papers)Inflammasome and immune disorders (5 papers)Cytokine Signaling Pathways and Interactions (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xiangyang Xiong

31 papers receiving 654 citations

Peers

Xiangyang Xiong
Comparison fields: 5 of 99
  • Molecular Biology 333
  • Oncology 162
  • Immunology 140
  • Cancer Research 125
  • Physiology 59
Replace Hidenori Bando with:
Hidenori Bando Japan
Vanida A. Serna United States
Aneesha Radhakrishnan India
Giuliana P. Mognol Brazil
Erica V. Stein United States
Rita Lopes United Kingdom
Dandan Lv China
Christian Goepfert United States
Jiannong Cen China
Rodolfo Daniel Cervantes‐Villagrana Mexico
Xiangyang Xiong relative to Hidenori Bando Japan Hidenori Bando's profile →
Citations per field
00.5×4.8×
Hidenori Bando · 1×
Citations per year

Countries citing papers authored by Xiangyang Xiong

Since Specialization
Citations

This map shows the geographic impact of Xiangyang Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Xiong more than expected).

Fields of papers citing papers by Xiangyang Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Xiong. The network helps show where Xiangyang Xiong may publish in the future.

Co-authorship network of co-authors of Xiangyang Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Xiong. A scholar is included among the top collaborators of Xiangyang Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Xiong. Xiangyang Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 11
4 11
5 8
6 19
7 23
8 6
9 3
10 15
11 13
12 6
13 14
14 0
15 22
16 92
17 94
18 13
19 35
20 24

About Xiangyang Xiong

Xiangyang Xiong is a scholar working on Biological Psychiatry, Oncology and Cancer Research, having authored 35 papers that have together received 657 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Inflammasome and immune disorders (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Cancer Research (125 citations), Immunology (140 citations) and Oncology (162 citations). Xiangyang Xiong has collaborated with scholars based in China and United States. Frequent co-authors include Xiaohua Yan, Ye‐Guang Chen, Li Liu, Yudong Wu, Yangyang Liu, Shiwen Luo, Shuo Tu, Chong Zhou, Chengmei Liu and Yong Li. Their work appears in journals such as Experimental Cell Research, Life Sciences and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026